AHA News: She Had a Baby. Then Emergency Heart Surgery. And a Stroke. Then, a New Heart.
THURSDAY, July 29, 2021 (American Heart Association News) -- In her third trimester, Kristy Novillo struggled to give tours of the Redmond, Washington, child care center where she worked as a director. Walking and talking at the same time left her... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 29, 2021 Category: General Medicine Source Type: news

Shortages Reveal Low Priority of Women ’s Health in Nepal
Chiring Tamang holds the family’s new baby while his wife Priya looks on. She delivered the girl at home in their village in Nepal’s Sindhupalchowk district in February 2021. Credit: Marty Logan / IPSBy Marty LoganKathmandu, Nepal, Jul 21 2021 (IPS) One year after Nepal’s Ministry of Health (MoH) appealed to international organisations in the country to urgently supply a drug used to stop excessive bleeding after childbirth, a UN agency has delivered $1 million worth of contraceptives to prevent another shortage. The 1.6 million cycles of oral contraceptive pills and 776,000 units of injectable contracep...
Source: IPS Inter Press Service - Health - July 21, 2021 Category: International Medicine & Public Health Authors: Marty Logan Tags: Asia-Pacific COVID-19 Featured Gender Headlines Health Human Rights Humanitarian Emergencies Inequity TerraViva United Nations Women's Health contraceptives UNFPA United Nations Population Fund (UNFPA) Source Type: news

AHA News: Pregnant Mom's Diet May Influence Baby's Cardiovascular Health
MONDAY, July 19, 2021 (American Heart Association News) -- A pregnant woman's diet and other lifestyle factors may change how her baby's genes work in a way that can affect the child's cardiovascular health by age 8 or 9, new research has... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 19, 2021 Category: General Medicine Source Type: news

Hope, horror and Covid-19: my 23 years as the Guardian ’s health correspondent | Sarah Boseley
I ’ve travelled the world covering everything from HIV to MMR to Ebola… and then Covid came along. These are stories that changed me – and the worldShe was tall, wrapped in a green patterned dress that clung to her legs and ended just above dusty flip-flops. In the bustling, sweltering market, Grace Mathanga looked at me appraisingly, as if to say: “What have we here?” And I knew she was the one.It was the end of2002. I had flown to Lilongwe, the capital of Malawi, with excitement in my heart and fear of failure eating at my gut. I ’d been the Guardian’s health correspondent for a...
Source: Guardian Unlimited Science - July 17, 2021 Category: Science Authors: Sarah Boseley Tags: Health Coronavirus Aids and HIV Infectious diseases Vaccines and immunisation Society Ebola Africa Epidemics World news Global health Global development Campaigning journalism Newspapers & magazines Media Source Type: news

New research aims to improve treatments and outcomes for people with severe asthma
(Cleveland Clinic) A new phase 2 clinical trial of multiple therapies for severe asthma is underway in Northeast Ohio, with a focus on personalized therapies based on genetics, family history, lifestyle and environmental factors.The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE) study, sponsored by the National Heart, Lung and Blood Institute (NHBLI), is enrolling patients at Cleveland Clinic and University Hospitals Rainbow Babies& Children's Hospital. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2021 Category: International Medicine & Public Health Source Type: news

STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
SPRING HOUSE, PENNSYLVANIA, July 9, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new three-year data from the long-term extension (LTE) of the STELARA® (ustekinumab) Phase 3 UNIFI study. The data demonstrated the majority (55.2 percent) of adult patients with moderately to severely active ulcerative colitis (UC) who initially responded to treatment with STELARA sustained symptomatic remissiona rates at nearly three years (week 152).1 Furthermore, a majority (96.4 percent) of the patients in symptomatic remissiona at week 152 were corticosteroid-free. These data are being pr...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Featured review: Low-dose misoprostol given by mouth for induction of labour
First author of this new Cochrane Review,' Low ‐dose oral misoprostol for induction of labour', Robert Kerr explains, “Our review found that Misoprostol given orally outperforms the ‘gold-standard’ drug which is much more expensive, and used in preference in many countries. This review has the potential to impact millions of women and babies who have inductions of labour through its comparison of oral misopro stol with other commonly used induction techniques. " Labour inductions are common around the world. Induction rates vary worldwide, but for example in the UK, 1 in 3 women will have labo...
Source: Cochrane News and Events - June 28, 2021 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with co...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Too Many Older Americans Are Taking Daily Aspirin
TUESDAY, June 22, 2021 -- Many older adults are still taking a daily baby aspirin to ward off first-time heart problems— despite guidelines that now discourage it, a new study finds. Researchers found that one-half to 62% of U.S. adults aged... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 22, 2021 Category: General Medicine Source Type: news

AHA News: Preterm Babies May Have Higher Stroke Risk as Young Adults
Title: AHA News: Preterm Babies May Have Higher Stroke Risk as Young AdultsCategory: Health NewsCreated: 6/17/2021 12:00:00 AMLast Editorial Review: 6/18/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 18, 2021 Category: Cardiology Source Type: news

AHA News: Preterm Babies May Have Higher Stroke Risk as Young Adults
THURSDAY, June 17, 2021 (American Heart Association News) -- Babies born prematurely may have significantly higher risk of stroke as young adults– and the earlier the birth, the greater the risk, suggests an extensive new study. Although... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 17, 2021 Category: General Medicine Source Type: news

Almost 25% of COVID-19 Patients Develop Long-Lasting Symptoms, According to a New Report
A year and a half into the pandemic, the condition known as Long COVID continues to stump doctors. A significant number of patients develop long-term symptoms after catching COVID-19, but it hasn’t been clear why that happens, who is likely to get sick or even how many people continue to suffer. A large new study may help form some answers to those questions. In line with prior estimates, it finds that almost a quarter of people infected with the virus develop at least one lingering health problem, and that most Long COVID symptoms are more commonly reported by women than men. [time-brightcove not-tgx=”true&rdq...
Source: TIME: Health - June 15, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

‘A Year Full of Emotions.’ What Kids Learned From the COVID-19 Pandemic
Too many young generations have been shaped by the global crises they faced—Depression-era poverty, Cold War nuclear fears. Add to them the COVID generation. The virus itself may typically go easier on kids than it does adults, but the mind of a child is another thing. It’s dependent on certainty, safety, the comfort of routine. Take all of that away—shutter schools, keep grandparents at a distance, cancel summer camps—and kids suffer. But as the following lightly-edited stories from young people show, they also grow and learn, gain maturity and wisdom. The virus has been tough; plenty of kids, it t...
Source: TIME: Health - June 12, 2021 Category: Consumer Health News Authors: Jeffrey Kluger and Allison Singer Tags: Uncategorized COVID-19 Source Type: news

New Phase 3b Psoriatic Arthritis (PsA) Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Robust Joint Symptom Improvement and Complete Skin Clearance in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)
SPRING HOUSE, PENNSYLVANIA, June 2, 2021 – Today the Janssen Pharmaceutical Companies of Johnson & Johnson announced new efficacy and safety data for first-in-class TREMFYA® (guselkumab), including data from the first study evaluating a selective IL-23 inhibitor in adult patients with active PsA, all of whom had demonstrated inadequate response or intolerance to TNFi.1 In the COSMOS Phase 3b study, significantly higher proportions of patients treated with TREMFYA showed joint symptom improvement and complete skin clearance versus placebo at week 24 in this true TNFi-IRa patient population, which is often more...
Source: Johnson and Johnson - June 2, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

UCLA Health clinic helps mom heal after near-death birth experience
Marisa Peters, a 38-year-old mom of three, expected the delivery of her third child to be ordinary and uneventful, just like the births of her two other children. But right after her water broke at Ronald Reagan UCLA Medical Center on Feb. 6, 2019, she became quickly aware that this delivery would be very different.The first sign was a high fever that escalated rapidly. Then she developed an infection and began experiencing full-body convulsions, which were followed by a painful singular contraction that lasted for one hour. During this time, the baby ’s heart rate dipped, but she was lucky to catch a small window of...
Source: UCLA Newsroom: Health Sciences - May 26, 2021 Category: Universities & Medical Training Source Type: news

Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn ’s Disease
SPRING HOUSE, PENNSYLVANIA, May 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohn’s disease (CD) and ulcerative colitis (UC),1-4including data from the SEAVUE study, the first head-to-head study of biologic therapies in patients with CD, presented in a Clinical Science Late-Breaking Abstract Plenary session.1 SEAVUE data showed treatment with STELARA demonstrated high rates of clinical remission, corticosteroid-free remission, clinical response and endoscopic response through one year in biologic-naïve p...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

AHA News: A Baby's Gut Bacteria May Predict Future Obesity
THURSDAY, May 20, 2021 (American Heart Association News) -- New research into the growing problem of early childhood obesity suggests the bacteria in a baby's gut may indicate weight problems in the years to come. Researchers examined gut microbiota... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 20, 2021 Category: General Medicine Source Type: news

Late-Breaking Data at ACC.21 Show XARELTO ® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization
RARITAN, N.J., May 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced severe vascular events in patients with peripheral artery disease (PAD) after lower-extremity revascularization (LER) compared to aspirin alone regardless of whether it was the first, second, third, or subsequent event. The primary results of VOYAGER PAD showed that XARELTO® plus aspirin reduced first events by 15 percent among patients...
Source: Johnson and Johnson - May 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

AHA News: Preterm Deliveries May Pose Long-Term Stroke Risk for Mothers
MONDAY, May 10, 2021 (American Heart Association News) -- It's not surprising that babies born prematurely may face more health issues than those who were carried to term. But new research suggests the same may apply to their mothers. A study... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 10, 2021 Category: General Medicine Source Type: news

Genetically Modified Mosquitoes Have Come to the U.S. Will They Work?
“Our Mosquito Project Takes Flight,” reads a baby-blue billboard off US-1 in the Florida Keys, alongside an image of an insect tracing a path in the shape of a heart. Sponsored by the local mosquito control board and U.K.-based biotech firm Oxitec, the ad promotes a contentious plan to release millions of genetically modified Aedes aegypti mosquitoes here to test a new method of bioengineered pest control. It’s the first-ever such experiment in the United States, and one that has turned this chain of sun-soaked island communities into a battleground over scientific truth, government authority, and humanit...
Source: TIME: Health - May 9, 2021 Category: Consumer Health News Authors: Alejandro de la Garza / Florida Keys, Fl. Tags: Uncategorized Source Type: news

Researchers describe rare case of heart rhythm problem in newborn with Turner syndrome
(Boston University School of Medicine) Doctors treating babies born with Turner syndrome need to look for heart rhythm abnormalities, in addition to the usual heart problems of high blood pressure or left-sided structural heart defects, according to Meena Bolourchi, MD, assistant professor of pediatrics at Boston University School of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 30, 2021 Category: International Medicine & Public Health Source Type: news

New Phase 3 Data Showed First-in-Class TREMFYA ® (guselkumab) Provided Durable Complete Skin Clearance Through Five Years in Moderate to Severe Plaque Psoriasis (PsO) and Robust Joint Symptom Improvement Through 52 Weeks in Active Psoriatic Arthritis (PsA)
SPRING HOUSE, PENNSYLVANIA, April 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new Phase 3 data which showed TREMFYA® (guselkumab) sustained durable, complete skin clearance rates in a majority of adults with moderate to severe plaque psoriasis (PsO) through five years (252 weeks), a and improved disease activity and axial symptoms in adults with active psoriatic arthritis (PsA) through one year (52 weeks).1,2,3 These data are being presented at the American Academy of Dermatology Virtual Meeting Experience 2021, where Janssen will present a total of 22 abstracts. TREMF...
Source: Johnson and Johnson - April 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Johnson & Johnson Reports 2021 First-Quarter Results
New Brunswick, N.J. (April 20, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2021. “Johnson & Johnson delivered a strong first quarter performance led by the above market growth of our Pharmaceutical business and continued recovery in Medical Devices,” said Alex Gorsky, Chairman and Chief Executive Officer. “The ability to deliver these results while simultaneously advancing our robust pipeline of life-enhancing medicines, products and solutions during these times is a testament to the strength and resilience of our business and the dedication of the 135,000...
Source: Johnson and Johnson - April 20, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

'Baby, that's the police': Woman in SUV said cop came to window with gun drawn
Defense attorney Eric Nelson has contended that George Floyd died from serious heart problems combined with illicit drug use, rather... (Source: Reuters: Health)
Source: Reuters: Health - April 13, 2021 Category: Consumer Health News Source Type: news

Aaliyah ’s mother reacts to DMX’s death: ‘You and baby girl will meet again’
‘Earl, you had and still have a heart of gold’ (Source: Reuters: Health)
Source: Reuters: Health - April 9, 2021 Category: Consumer Health News Source Type: news

Stethoscope Remains Best Way to Monitor Fetal Distress During Labor
WEDNESDAY, April 7, 2021 -- Listening to a fetal heart rate using a stethoscope is still the best method for determining whether a baby is in distress during delivery, according to a review published online April 6 in CMAJ, the journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 7, 2021 Category: Pharmaceuticals Source Type: news

Reproduction without pregnancy: would it really emancipate women? | Jenny Kleeman
It may sound far-fetched, but a breakthrough in Israel has brought us a step closer to creating artificial wombs for humansA team of Israeli scientists announced the mother of all inventions last week. Researchers from the Weizmann Institute of Science revealedin the journal Nature that they had successfully gestated hundreds of mice inside an artificial womb. They placed newly fertilised eggsinside glass vials rotating in a ventilated incubator, and grew the embryos for 11 days – the mid-point of a mouse pregnancy – outside their mothers’ bodies. The embryos developed normally; their hearts, visible thro...
Source: Guardian Unlimited Science - March 25, 2021 Category: Science Authors: Jenny Kleeman Tags: Reproductive rights Reproduction Science Health Fertility problems Society Parents and parenting Women World news Source Type: news

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profi...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

New Phase 3 Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Complete Skin Clearance and Favorable Joint Efficacy in Adult Patients with Active Psoriatic Arthritis (PsA) Through Two Years
SPRING HOUSE, PENNSYLVANIA, March 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced long-term data from the Phase 3 DISCOVER-2a study showing that the skin clearance, joint symptom relief, and safety of TREMFYA® (guselkumab) previously demonstrated through 24 weeks and one year (Week 52) in adults with active psoriatic arthritis (PsA) continued through two years (Week 112).1,2 These findings also confirmed that the robust efficacy TREMFYA demonstrated in patients at Week 24 on physical function, physical aspects of health-related quality of life, and resolution of enthesitis...
Source: Johnson and Johnson - March 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Does aspirin thin the blood? How much aspirin you should take - and when it can be harmful
ASPIRIN is a common painkiller that's usually used for headaches, flu, toothaches, and even fevers. But does aspirin thin the blood? Here's why 'baby aspirin' may be used to prevent heart attacks and strokes - and the amount of aspirin you should have to avoid harmful side-effects. (Source: Daily Express - Health)
Source: Daily Express - Health - March 12, 2021 Category: Consumer Health News Source Type: news

We read books to my daughter from birth, which enriched all our lives
A difficult pregnancy meant the only item I dared buy for my unborn child was a book. When she arrived we read it to her every dayNine years ago, I gave birth to a little girl. And now that little girl has grown into abookworm. It began, as all stories about books should really begin, in a bookshop. I was several months pregnant and I picked up an American picture book I had never come across before:Goodnight Moon by Margaret Wise Brown. It featured a poem that my husband and I would end up reading, oh, I don ’t know, at least 900 times. The book became such a pillar of my daughter’s nightly routine that by the...
Source: Guardian Unlimited Science - March 6, 2021 Category: Science Authors: Donna Ferguson Tags: Children's books: 7 and under Pregnancy Parents and parenting Family Life and style Psychology Science Health & wellbeing Source Type: news

‘We Will Handle It.’ An Army of Women Is Taking on the Hunger Crisis in Local Communities
Just before 3 p.m. on a warm Wednesday in February, 30-year-old Jammella Anderson—­donning heart-shaped glasses, a Black Lives Matter tee and 2-in. platform boots—strolls up to a small bicycle-­repair shop just north of Albany, N.Y. She’s here to persuade Troy Bike Rescue to let her use an electrical outlet so she can plug in a new refrigerator just outside the shop’s front door. “It’s just two prongs,” she explains to one of the employees. “All I need is an outlet.” Anderson, who works as a part-time doula and yoga instructor, is here on behalf of the one-woman...
Source: TIME: Health - March 3, 2021 Category: Consumer Health News Authors: Abby Vesoulis and Mariah Espada Tags: Uncategorized COVID-19 feature food insecurity Magazine Women in Crisis Source Type: news

Africa: Baby Infected With Coronavirus in the Womb - New Study
[The Conversation Africa] A pregnant woman with suspected COVID-19 was rushed by ambulance to Sk åne University Hospital, in Malmo, Sweden, suffering from sudden severe abdominal pain. The doctors noticed that the unborn infant had an abnormally low heart rate, which can be a sign that the baby is not getting enough oxygen. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 2, 2021 Category: African Health Source Type: news

New research at UH Rainbow studies the impact of face masks on heart ra
(University Hospitals Cleveland Medical Center) Researchers at University Hospitals Rainbow Babies& Children's Hospital (UH Rainbow) published new findings today that wearing a face mask -- either a cloth mask or a surgical mask -- did not impair the ability of subjects to get air in and out of their bodies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 24, 2021 Category: International Medicine & Public Health Source Type: news

Baby mice have a skill that humans want - and this microchip might help us learn it
(University of New South Wales) A new microchip could help scientists uncover secrets of heart regeneration in baby mice. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 24, 2021 Category: Biology Source Type: news

AHA News: Hoping to Find Out Her Baby's Sex, She Learned of a Serious Heart Defect
FRIDAY, Feb. 12, 2021 (American Heart Association News) -- Latisha Wilborne was excited. She and her husband had tried for a year to get pregnant, and now, 20 weeks pregnant, she was at a doctor's visit with her two sisters where an ultrasound would... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 12, 2021 Category: General Medicine Source Type: news

Using wearable tech to keep babies, pregnant women healthy
(West Virginia University) A new study explored how a wearable device called WHOOP could be used to monitor pregnant women's resting heart rate and heart rate variability. The data collected from the devices shed light on the fitness changes that can take place during and after pregnancy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 27, 2021 Category: International Medicine & Public Health Source Type: news

Research in Newcastle to further study the role of genes in congenital heart defects
(British Heart Foundation) New research funded by the British Heart Foundation (BHF) at Newcastle University will study how certain genes could lead to heart blood vessel defects in babies. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 27, 2021 Category: Biology Source Type: news

Johnson & Johnson Reports 2020 Fourth-Quarter and Full Year Results
New Brunswick, N.J. (January 26, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2020. “Our notable full year performance reflects the continued confidence from patients, physicians, customers and consumers in our life-enhancing products and medicines, particularly throughout the COVID-19 pandemic,” said Alex Gorsky, Chairman and Chief Executive Officer. “I’m incredibly proud of our Johnson & Johnson teams around the world for going above and beyond to meet stakeholder needs. These efforts, and our commitment to families around the world a...
Source: Johnson and Johnson - January 26, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Coronavirus live news: global death toll passes milestone as Emirates cancels Australian flights
Global coronavirus death toll reaches 2 million people;UK shuts travel corridors and requires negative Covid tests to enter;German vaccine officials forced to guess who is eligible from namesBrazil rushes to save premature babies as Covid swamps hospitalsVaccine passports: what are they and do they pose a danger to privacy?US suffers bleak January as Covid rages and vaccination campaign falters‘At the coalface’: what the Australian expert in WHO’s Covid mission in China hopes to find12.44amGMTHere ’s our story on a grim landmark. The world has now passed 2m deaths from Covid-19.“Our world has ...
Source: Guardian Unlimited Science - January 16, 2021 Category: Science Authors: Michael McGowan Tags: Coronavirus Infectious diseases Science World news Source Type: news

AHA News: Baby Born With Heart Defect Faces More Challenges After Stroke
THURSDAY, Jan. 14, 2021 (American Heart Association News) -- Kayla Scritchfield had a normal pregnancy and delivered her second daughter, Ava, thinking all was well. About six hours later, Ava looked purple. Medical personnel whisked away the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 14, 2021 Category: General Medicine Source Type: news

AHA News: Baby Born With Heart Defect Faces More Challenges After Stroke
Title: AHA News: Baby Born With Heart Defect Faces More Challenges After StrokeCategory: Health NewsCreated: 1/14/2021 12:00:00 AMLast Editorial Review: 1/14/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 14, 2021 Category: Cardiology Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Health - January 11, 2021 Category: Consumer Health News Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Science - January 11, 2021 Category: Science Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer
This article originally appeared on Detroit Free Press: Detroit paramedic Jon A. Bozich, 45, dies of cancer ___ (c)2020 the Detroit Free Press Visit the Detroit Free Press at www.freep.com Distributed by Tribune Content Agency, LLC. The post Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer appeared first on JEMS. (Source: JEMS Special Topics)
Source: JEMS Special Topics - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: News News Feed Cancer Michigan Paramedic Source Type: news

Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer
This article originally appeared on Detroit Free Press: Detroit paramedic Jon A. Bozich, 45, dies of cancer ___ (c)2020 the Detroit Free Press Visit the Detroit Free Press at www.freep.com Distributed by Tribune Content Agency, LLC. The post Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer appeared first on JEMS. (Source: JEMS Operations)
Source: JEMS Operations - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: News News Feed Cancer Michigan Paramedic Source Type: news

Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer
This article originally appeared on Detroit Free Press: Detroit paramedic Jon A. Bozich, 45, dies of cancer ___ (c)2020 the Detroit Free Press Visit the Detroit Free Press at www.freep.com Distributed by Tribune Content Agency, LLC. The post Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer appeared first on JEMS. (Source: JEMS: Journal of Emergency Medical Services News)
Source: JEMS: Journal of Emergency Medical Services News - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: News News Feed Cancer Michigan Paramedic Source Type: news

Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer
This article originally appeared on Detroit Free Press: Detroit paramedic Jon A. Bozich, 45, dies of cancer ___ (c)2020 the Detroit Free Press Visit the Detroit Free Press at www.freep.com Distributed by Tribune Content Agency, LLC. The post Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer appeared first on JEMS. (Source: JEMS Patient Care)
Source: JEMS Patient Care - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: News News Feed Cancer Michigan Paramedic Source Type: news

Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer
This article originally appeared on Detroit Free Press: Detroit paramedic Jon A. Bozich, 45, dies of cancer ___ (c)2020 the Detroit Free Press Visit the Detroit Free Press at www.freep.com Distributed by Tribune Content Agency, LLC. The post Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer appeared first on JEMS. (Source: JEMS Administration and Leadership)
Source: JEMS Administration and Leadership - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: News News Feed Cancer Michigan Paramedic Source Type: news

Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer
This article originally appeared on Detroit Free Press: Detroit paramedic Jon A. Bozich, 45, dies of cancer ___ (c)2020 the Detroit Free Press Visit the Detroit Free Press at www.freep.com Distributed by Tribune Content Agency, LLC. The post Detroit Paramedic Jon A. Bozich, 45, Dies of Cancer appeared first on JEMS. (Source: JEMS Latest News)
Source: JEMS Latest News - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: News News Feed Cancer Michigan Paramedic Source Type: news